Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 2
1964 3
1966 1
1968 1
1969 4
1970 3
1971 1
1972 1
1974 2
1975 4
1976 2
1977 2
1978 1
1979 9
1980 9
1981 15
1982 14
1983 12
1984 7
1985 15
1986 18
1987 19
1988 21
1989 13
1990 18
1991 19
1992 15
1993 21
1994 32
1995 18
1996 20
1997 23
1998 28
1999 27
2000 34
2001 31
2002 25
2003 34
2004 27
2005 31
2006 41
2007 31
2008 45
2009 45
2010 36
2011 48
2012 52
2013 54
2014 44
2015 45
2016 51
2017 64
2018 46
2019 56
2020 57
2021 65
2022 57
2023 47
2024 52
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,380 results

Results by year

Filters applied: . Clear all
Page 1
Mechanisms of kidney fibrosis and routes towards therapy.
Yamashita N, Kramann R. Yamashita N, et al. Trends Endocrinol Metab. 2024 Jan;35(1):31-48. doi: 10.1016/j.tem.2023.09.001. Epub 2023 Sep 28. Trends Endocrinol Metab. 2024. PMID: 37775469 Review.
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.
Haratake N, Ozawa H, Morimoto Y, Yamashita N, Daimon T, Bhattacharya A, Wang K, Nakashoji A, Isozaki H, Shimokawa M, Kikutake C, Suyama M, Hashinokuchi A, Takada K, Takenaka T, Yoshizumi T, Mitsudomi T, Hata AN, Kufe D. Haratake N, et al. Among authors: yamashita n. J Thorac Oncol. 2024 Mar;19(3):434-450. doi: 10.1016/j.jtho.2023.10.017. Epub 2023 Nov 3. J Thorac Oncol. 2024. PMID: 37924972 Free article.
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. Yasumizu Y, et al. Among authors: yamashita n. Nat Commun. 2020 Jan 17;11(1):338. doi: 10.1038/s41467-019-14219-6. Nat Commun. 2020. PMID: 31953400 Free PMC article.
The importance of proinflammatory failed-repair tubular epithelia as a predictor of diabetic kidney disease progression.
Tomita-Yagi A, Ozeki-Okuno N, Watanabe-Uehara N, Komaki K, Umehara M, Sawada-Yamauchi H, Minamida A, Sunahara Y, Matoba Y, Nakamura I, Nakata T, Nakai K, Ida T, Yamashita N, Kamezaki M, Kirita Y, Taniguchi T, Konishi E, Matoba S, Tamagaki K, Kusaba T. Tomita-Yagi A, et al. Among authors: yamashita n. iScience. 2024 Jan 26;27(2):109020. doi: 10.1016/j.isci.2024.109020. eCollection 2024 Feb 16. iScience. 2024. PMID: 38357667 Free PMC article.
Virological aspects of Epstein-Barr virus infections.
Yamashita N, Kimura H, Morishima T. Yamashita N, et al. Acta Med Okayama. 2005 Dec;59(6):239-46. doi: 10.18926/AMO/31961. Acta Med Okayama. 2005. PMID: 16418766 Free article. Review.
Phase II Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 and Cisplatin for Gastric Cancer with Peritoneal Metastasis.
Kobayashi D, Kodera Y, Fukushima R, Morita M, Fushida S, Yamashita N, Yoshikawa K, Ueda S, Yabusaki H, Kusumoto T, Arigami T, Hidemura A, Omori T, Yamaguchi H, Hirono Y, Tsuji Y, Moon JH, Tomita T, Imamura H, Nakanishi K, Shimizu D, Hirakawa A, Ishigami H, Kitayama J. Kobayashi D, et al. Among authors: yamashita n. Ann Surg Oncol. 2024 Feb;31(2):735-743. doi: 10.1245/s10434-023-14240-6. Epub 2023 Nov 11. Ann Surg Oncol. 2024. PMID: 37952018 Clinical Trial.
1,380 results